Vascular endothelial growth factor isoforms differentially protect neurons against neurotoxic events associated with Alzheimer’s disease

Vascular endothelial growth factor isoforms differentially protect neurons against neurotoxic events associated with Alzheimer’s disease

Alzheimer’s disease (AD) is the most common cause of dementia, the chronic and progressive deterioration of memory and cognitive abilities. AD can be pathologically characterised by neuritic plaques and neurofibrillary tangles, formed by the aberrant aggregation of β-amyloid and tau proteins, respec...

Full description

Bibliographic Details
Main Authors:	Roaa H. Alalwany, Tom Hawtrey, Kevin Morgan, Jonathan C. Morris, Lucy F. Donaldson, David O. Bates
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Molecular Neuroscience
Subjects:	Alzheimer’s disease VEGF splicing tau SRPK1 amyloid-beta
Online Access:	https://www.frontiersin.org/articles/10.3389/fnmol.2023.1181626/full

Similar Items

SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells
by: Preenapan Changphasuk, et al.
Published: (2024-09-01)

Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
by: Shinsuke Araki, et al.
Published: (2023-06-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

Impaired expression of serine/arginine protein kinase 2 (SRPK2) affects melanoma progression
by: Mônica Maria Magalhães Caetano, et al.
Published: (2022-09-01)

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
by: Linda J. Van Eldik, et al.
Published: (2024-10-01)

Synaptic activity and Alzheimer’s disease: a critical update
by: Davide eTampellini
Published: (2015-11-01)

Dityrosine cross-linking and its potential roles in Alzheimer’s disease
by: Mahmoud B. Maina, et al.
Published: (2023-03-01)

Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function
by: Erin E. Sundermann, et al.
Published: (2023-06-01)

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
by: Josef Marksteiner, et al.
Published: (2022-09-01)

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
by: Marcella Catania, et al.
Published: (2019-11-01)

Wading pools and fading memories – place navigation in transgenic mouse models of Alzheimer’s disease
by: Heikki eTanila
Published: (2012-06-01)

Evaluation of core Biomarkers of Alzheimer’s disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform
by: Luisa Agnello, et al.
Published: (2024-07-01)

Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
by: Robert A. Whittington, et al.
Published: (2017-11-01)

Frontal lobe microglia, neurodegenerative protein accumulation, and cognitive function in people with HIV
by: Jacinta Murray, et al.
Published: (2022-05-01)

Recent advancements toward therapeutic vaccines against Alzheimer’s disease
by: Krystal Herline, et al.
Published: (2018-08-01)

The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease
by: Shiting Weng, et al.
Published: (2022-06-01)

From Small Peptides to Large Proteins against Alzheimer’sDisease
by: Pasquale Picone, et al.
Published: (2022-09-01)

Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome
by: Elizabeth J. Andrews, et al.
Published: (2022-08-01)

From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients
by: Ioanna Tsantzali, et al.
Published: (2021-10-01)

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
by: Zdeněk Fišar
Published: (2022-11-01)

SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma
by: Hongda Liu, et al.
Published: (2021-02-01)

Alzheimer’s disease: an axonal injury disease?
by: Liang Dan, et al.
Published: (2023-10-01)

The Functions and Phenotypes of Microglia in Alzheimer’s Disease
by: Risako Fujikawa, et al.
Published: (2023-04-01)

Targeting Microglia in Alzheimer’s Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules
by: Ziyad M. Althafar
Published: (2022-06-01)

Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease
by: Cécile Tissot, et al.
Published: (2021-01-01)

Recognizing Atypical Presentations of Alzheimer’s Disease: The Importance of CSF Biomarkers in Clinical Practice
by: George P. Paraskevas, et al.
Published: (2022-12-01)

Novel targets for the treatment and prevention of Alzheimer's disease in the European population, inspiration from amyloid beta and tau protein
by: Xifeng Wang, et al.
Published: (2024-10-01)

Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from <i>Caenorhabditis elegans</i> Transgenic Models
by: María D. Navarro-Hortal, et al.
Published: (2022-05-01)

Perivascular spaces as a potential biomarker of Alzheimer’s disease
by: Miranda Lynch, et al.
Published: (2022-10-01)

The role of autophagy in Alzheimer's disease and its potential for therapy
by: Min LIU, et al.
Published: (2014-05-01)

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
by: Anushka Chakravorty, et al.
Published: (2019-11-01)

Cerebrospinal Fluid Classical Biomarker Levels in Mixed vs. Pure A<sup>+</sup>T<sup>+</sup> (A<sup>+</sup>T<sub>1</sub><sup>+</sup>) Alzheimer’s Disease
by: Ioanna Tsantzali, et al.
Published: (2024-12-01)

Progress on the correlation between exosomal microRNAs and Alzheimer's disease
by: DIAO Hua-qiong, LI Xiao-li, LIN Liang-yin, LIU Hai-peng, CHEN Hong-jing, DING Hai-yue, WEI Dan
Published: (2020-11-01)

Perturbations of Ubiquitin-Proteasome-Mediated Proteolysis in Aging and Alzheimer’s Disease
by: Ashok N. Hegde, et al.
Published: (2019-12-01)

Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease
by: Ling-Chun Huang, et al.
Published: (2022-08-01)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
by: Alejandro R Roda, et al.
Published: (2022-01-01)

The Potential Mechanism and the Role of Antioxidants in Mitigating Oxidative Stress in Alzheimer’s Disease
by: Rayees Ahmad Naik, et al.
Published: (2025-02-01)

Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells
by: Ioanna Sigala, et al.
Published: (2021-03-01)

Good Cop, Bad Cop: The Different Roles of SRPKs
by: Eleni Nikolakaki, et al.
Published: (2022-06-01)

Review Paper: Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
by: Nahid Ahmadian, et al.
Published: (2018-09-01)